tiprankstipranks
Trending News
More News >
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Similar Stocks

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$26.00
HK$10.22B
72.16
210.26%
Ascletis Pharma, Inc.
HK$12.63
HK$13.12B
-44.32
413.41%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$5.16
HK$9.89B
-45.83
57.32%
1 Buy
0 Hold
0 Sell
Moderate Buy
Keymed Biosciences, Inc.
HK$62.80
HK$15.27B
-52.49
59.58%
4 Buy
0 Hold
0 Sell
Strong Buy
CARsgen Therapeutics Holdings Ltd.
HK$14.81
HK$8.40B
-14.90
70.43%
0 Buy
0 Hold
0 Sell
Moderate Buy
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.71
HK$5.42B
140.94
0.11%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
26.00
17.62
210.26%
HK:1672
Ascletis Pharma, Inc.
12.63
10.17
413.41%
HK:2157
Lepu Biopharma Co. Ltd. Class H
5.16
2.02
64.33%
HK:2162
Keymed Biosciences, Inc.
53.70
20.80
63.22%
HK:2171
CARsgen Therapeutics Holdings Ltd.
14.81
6.12
70.43%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.71
0.01
0.11%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts